CTOs on the Move


 
CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept ...
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.cequrcorp.com
  • 734 Forest Street Suite 100
    Marlborough, MA USA 01752
  • Phone: 508.486.0010

Executives

Name Title Contact Details

Funding

CeQur raised $100M on 09/01/2015

Similar Companies

Tactx Medical Produxx

Tactx Medical Produxx is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

World Heart Corporation

World Heart Corporation is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Normed

Normed is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Z-Medica Corporation

Z-Medica, LLC is a privately-held medical device manufacturer based in Wallingford, CT that is focused on the development, sale, and marketing of innovative hemorrhage control products for healthcare providers, military personnel, the law enforcement community, first responders, and consumers around the globe. For over a decade, Z-Medica has helped save lives and improve medical outcomes with a growing portfolio of QuikClot hemostatic products that include Control, 4x4 Hemostatic Dressing, Radial, Interventional, Combat Gauze, Belt Trauma Kit, and Bleeding Control Bag. QuikClot products are manufactured in the United States.

TransMedics

TransMedics Inc. is the world`s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. The company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the heath care system. The OCS Lung, OCS Heart and OCS Liver are all CE marked and FDA approved devices.